Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4320295 | 0.81 | CYP2A6 (0.38) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL1230294 | 0.81 | CYP2A6 (0.38) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL220074 | 0.80 | MAPT (0.47) | CYP2A6MAPTCHRNA7ALDH1A1KDM4E | |
| SCHEMBL11716929 | 0.79 | MAPT (0.37) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL7469958 | 0.78 | MAPT (0.45) | CYP2A6MAPTCHRNA7ALDH1A1KDM4E | |
| SCHEMBL23149109 | 0.77 | ALDH1A1 (0.38) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL16546592 | 0.76 | ALDH1A1 (0.40) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL9804700 | 0.76 | ALDH1A1 (0.41) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL24871286 | 0.76 | ACHE (0.44) | MAPTCA1CA2CA9ALDH1A1 | |
| SCHEMBL4323037 | 0.76 | CYP2A6 (0.38) | CYP2A6MAPTCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240156994-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | TDK CORPORATION (JP) | 2024-05-16 | — | — | US | disclosed |
| CN-116981657-A | Fluorine-containing compound and contrast agent | TDK株式会社 | 2023-10-31 | — | — | CN | disclosed |
| WO-2022196734-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | TDK株式会社 | 2022-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240156994-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | AFF1, AFF2, AFF4 | CYP2A6 3523/4885MAPT 3105/4885CA1 704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.